Please login to the form below

Not currently logged in
Email:
Password:

simvastatin

This page shows the latest simvastatin news and features for those working in and with pharma, biotech and healthcare.

CETP inhibitor class finally dies as Merck abandons anacetrapib

CETP inhibitor class finally dies as Merck abandons anacetrapib

ezetimibe) and sister product Vytorin (ezetimibe plus simvastatin) - into a blockbuster franchise.

Latest news

More from news
Approximately 4 fully matching, plus 43 partially matching documents found.

Latest Intelligence

  • Rise of generic medicines in Portugal Rise of generic medicines in Portugal

    Pedro Pita Barros, professor of economics and Nova School of Business and Economics, told PME: “Patients have largely benefited from price decreases (for example, simvastatin dropped from above 50 for a ... Generics bestsellers in volume. Simvastatin.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...